Mealey's (April 21, 2021, 11:07 AM EDT) -- NEW ORLEANS — The Fifth Circuit U.S. Court of Appeals on April 19 affirmed defense summary judgment in a Taxotere hair loss case, saying there is insufficient evidence that a different warning about the risk of permanent hair loss from the chemotherapy drug would have changed the oncologist’s prescribing decision....